BDRelin Depot 3.75 mg Injection BDRelin Depot 3.75 mg contains Triptorelin Acetate 3.75 mg, a long-acting gonadotropin-releasing hormone (GnRH) analogue. It is supplied as a lyophilized depot injection and is administered by intramuscular injection under specialist medical supervision. The 3.75 mg formulation is designed for monthly treatment.

Effects & Benefits Helps suppress the production of sex hormones. Used in the management of hormone-dependent prostate cancer. May be used in endometriosis and other hormone-dependent conditions as prescribed. Provides long-acting hormonal suppression.